Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using remote ischemic preconditioning to prevent kidney injury during coronary angiograms

Official title: Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.

Run by The University of Texas Medical Branch, Galveston · NCT05147831 · Data updated 2026-11-12

This study is testing if a simple treatment called remote ischemic preconditioning can help protect the kidneys from injury during coronary angiograms in patients who are at risk.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorThe University of Texas Medical Branch, Galveston
Academic / other
Locations1 site (Galveston, Texas)
StatusRecruiting
StartedNovember 30, 2021
Main results expectedJuly 31, 2027
Study endsNovember 30, 2027
Registry record updatedOctober 5, 2026
Trial IDNCT05147831 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with renal clearance below 60 ml/min who are undergoing interventional or diagnostic procedures involving contrast media.

Probably not a fit

Patients on dialysis, those under 18 years old, or those with certain medical conditions that prevent RIPC will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of remote ischemic preconditioning (RIPC) as a preventive measure against contrast-induced acute kidney injury (CI-AKI) in patients undergoing coronary angiograms. CI-AKI is a significant risk associated with the use of contrast media during imaging procedures, leading to serious health complications. The study aims to determine if RIPC can reduce the rise in creatinine levels and the incidence of renal replacement therapy in moderate to high-risk patients. By employing a non-invasive and low-cost approach, the research seeks to establish a safe method to mitigate the risks of CI-AKI.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce the incidence of kidney injury in patients undergoing coronary angiograms.

How similar studies have gone: While the concept of remote ischemic preconditioning is promising, further randomized controlled trials are needed to confirm its effectiveness in preventing CI-AKI.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (1) Patients undergoing an interventional or diagnostic radiological procedure in which they receive intravascular contrast, including patients undergoing coronary angiogram +/- percutaneous coronary intervention (PCI) for all clinical indications except those indicated for primary PCI due to STEMI
* (2) patients presenting with a renal clearance in the range of less than 60 ml/min/1.73 m2 but not declared ESRD
* (3) Patients who are not yet recruited for other pharmacological or medical device clinical trials.

Exclusion Criteria:

* (1) Age \<18 years
* (2) Patient on hemodialysis or peritoneal dialysis
* (3) Simultaneous participation in another interventional study
* (4) Percutaneous coiling/embolization procedures of the kidney
* (5) Impossibility to perform RIPC, caused by pathology in both arms (e.g. dystrophy, recent trauma, chronic wounds)
* (6) No written informed consent
* (7) Urgent angiography in STEMI
* (8) Cardiogenic shock requiring catecholamine infusion
* (9) Systolic blood pressure \<80 mmHg
* (10) Intra-aortic balloon counter-pulsation
* (11) Contrast medium injection within the previous 30 days
* (12) Expected impossibility to obtain follow-up data at 6-week follow-up
* (13) Patients with Raynaud's disease

Where it's running

  • University of Texas- Medical Branch (UTMB)
    Galveston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.